Discover 3,564 paid clinical trials in Costa Mesa, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,564
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Los Angeles CA, Sylmar CA, Fresno CA, Phoenix AZ,
Sponsor: Origin Inc.
Sex: All
Age: 22 - 70+
Code: NCT03078933
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Orange CA, Los Angeles CA, Vancouver WA, San Antonio TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase2, Phase3, Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
for
Coronary Artery Disease
Location: Long Beach CA, Dallas TX, Houston TX, Birmingham AL,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05618353
Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
for
Psychotic Disorders, Alzheimer Disease
Location: Anaheim CA, Walnut Creek CA, Bellevue WA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06540833
Phase2, Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Orange CA, Fullerton CA, Phoenix AZ, Scottsdale AZ,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Orange CA, Los Angeles CA, Eugene OR, Portland OR,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221149
Phase2, Phase3, Recruiting
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours
for
Solid Tumours
Location: Orange CA, Los Angeles CA, Houston TX, St Louis MO,
Sponsor: Orion Corporation, Orion Pharma
Sex: All
Age: 18+
Code: NCT06725758
Phase1, Phase2, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06915753
Phase1, Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
for
Diffuse Large B-cell Lymphoma (DLBCL)
Location: Orange CA, Los Angeles CA, Scottsdale AZ, Sacramento CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091865
Phase3, Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Orange CA, Stanford CA, Sacramento CA, Aurora CO,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06128551
Phase1, Phase2, Recruiting
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Los Angeles CA, San Francisco CA, Madison WI,
Sponsor: Syntrix Biosystems, Inc.
Sex: Male
Age: 18+
Code: NCT06228053
Phase2, Recruiting
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Los Angeles CA
Sponsor: BioInvent International AB
Sex: All
Age: 18+
Code: NCT04219254
Phase1, Phase2, Recruiting
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)